Literature DB >> 6186598

Generation of anti-NZB red blood cell antibody-forming plasma cells from bone marrow cultures of syngeneic and allogeneic mice: functional modulation of helper T-cell subsets in autosensitization.

K Nakamura, T Akahoshi, A Yoshii, S Kashiwazaki.   

Abstract

An in vitro anti-NZB red blood cell (RBC) autoantibody-forming system was developed by culturing young (antiglobulin negative) or old (antiglobulin positive) NZB mouse bone marrow cells in the presence of young or old NZB thymocyte homogenates (or RNA thymus extracts) and young NZB-RBC. Using young NZB bone marrow cells, the greatest number of autoantibody forming cells were seen following stimulation with a mixture of young and old thymocyte homogenates (TH). A higher response was seen with old NZB bone marrow cells stimulated by old NZB thymocyte homogenates and RBC. Phenol-extracted thymic RNA retained activity when added to bone marrow culture containing NZB-RBC. Thymus RNA from 9 to 10 days old NZB mice had no activity although their bone marrow cells responded well to stimulation by young and old thymic RNA together with RBC. By analysing results obtained using T-cells enriched for helper and suppressor activities, we have concluded that abrogation of self-tolerance in mice is due to the appearance of functionally modulated helper T-cell subsets and to imbalance between helper and suppressor T cells.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6186598      PMCID: PMC1454044     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  13 in total

1.  The proliferation of plasma cells from mouse bone marrow in vitro. II-Stimulation of IgG-producing cells by a RNase-sensitive thymocyte homogenate.

Authors:  K Nakumura
Journal:  Cell Immunol       Date:  1976-08       Impact factor: 4.868

2.  Letter: Early autoantibody formation in lethally irradiated or drug-treated H-2-compatible recipients of pre-autoimmune NZB bone marrow or fetal liver cells.

Authors:  J I Morton; B V Siegel
Journal:  Transplantation       Date:  1974-06       Impact factor: 4.939

3.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

4.  The in vitro activity of peritoneal exudate cells from New Zealand black mice (NZB/B1) in the presence of I-125-BSA (bovine serum albumin).

Authors:  H I Thomas; D M Weir
Journal:  Clin Exp Immunol       Date:  1972-10       Impact factor: 4.330

Review 5.  Cellular events associated with the immunogenesis of anti-erythrocyte autoantibody responses of NZB mice.

Authors:  D H Deheer; T S Edginton
Journal:  Transplant Rev       Date:  1976

6.  Optimization of phenol extraction procedures for preparation of RNA from mammalian lymphoid organs.

Authors:  G D Griffin; H G Sellin; G D Novelli
Journal:  Anal Biochem       Date:  1978-07-01       Impact factor: 3.365

7.  Pathogenesis of autoimmunity in New Zealand mice. V. Loss of thymic suppressor function.

Authors:  A D Steinberg
Journal:  Arthritis Rheum       Date:  1974 Jan-Feb

8.  A model for the autosensitization autoantibody production associated with xenogeneic thymic RNA.

Authors:  K Nakamura; Y Nakamura; M Kawahara
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

9.  Immunoregulatory circuits among T-cell sets. II. Physiologic role of feedback inhibition in vivo: absence in NZB mice.

Authors:  H Cantor; L McVay-Boudreau; J Hugenberger; K Naidorf; F W Shen; R K Gershon
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

10.  The proliferation of plasma cells from mouse bone marrow in vitro. I. The role of thymus.

Authors:  K Nakamura
Journal:  J Exp Med       Date:  1972-03-01       Impact factor: 14.307

View more
  1 in total

1.  Pepsin like enzyme in macrophages and its role in the immune system.

Authors:  H Ohnishi
Journal:  Clin Exp Immunol       Date:  1984-10       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.